Buscar
Congreso SOLACI
Home Tags Cardiogenic shock

Tag: cardiogenic shock

AHA 2018 | Utilidad del balón de contrapulsación según el IABP-SHOCK II trial

AHA 2018 | Use of Balloon Counterpulsation According to IABP-SHOCK II Trial

solaci - 0
CULPRIT-SHOCK: los resultados a 1 año continúan soportando tratar solo la arteria culpable

ESC 2018 | CULPRIT-SHOCK: 1-Year Results Continue to Support Treatment of...

solaci - 0

Noradrenaline seems superior to adrenaline in patients with cardiogenic shock

solaci - 0
cerebral protection in TAVR

Complete Revascularization Is Beneficial in Acute MI with Cardiogenic Shock

solaci - 0

The CULPRIT-SHOCK Study Is Finally Published in NEJM and It Is...

solaci - 0

CULPRIT-SHOCK Results Will Transform Guidelines and Clinical Practice

solaci - 0
La asistencia previa con Impella 2.5 disminuye la mortalidad a 30 días en el shock cardiogénico por tronco de coronaria izquierda no protegido

Prior assistance with Impella 2.5 lowers 30-day mortality in cardiogenic shock due...

solaci - 0

Contemporary Ventricular Assist Devices: Hemodynamic Consequences

solaci - 0

Ventricular Assist Device in Acute Myocardial Infarction

solaci - 0

Survivors of Myocardial Infarction with Cardiogenic Shock: Long Term Outcomes.

solaci - 0
12Page 2 of 2

SOLACI es la organización de referencia del intervencionismo cardiovascular latinoamericano.

Últimas Noticias

Severe Tricuspid Regurgitation: Surgical vs. Transcatheter Edge-to-Edge Repair

Dr. Omar Tupayachi - 0
While highly prevalent, tricuspid regurgitation is a notably undertreated valvulopathy. Its progression has been associated with higher mortality and significant disability. According to the...

ACCESS-TAVI: Comparing Post TAVR Vascular Closure Devices

Dr. Andrés Rodríguez - 0
Transcatheter aortic valve replacement (TAVR) is a well-established option to treat elderly patients with severe symptomatic aortic valve stenosis. Technical advances and device development...

Endovascular Treatment of Iliofemoral Disease for the Improvement of Heart Failure with Preserved Ejection Fraction

Dr. Omar Tupayachi - 0
Peripheral artery disease (PAD) is a significant risk factor in the development of difficult-to-treat conditions, such as heart failure with preserved ejection fraction (HFpEF)....

Noticias Institucionales

Check out the best images of the El Salvador 2024 Sessions

solaci - 0
Review the highlights of the XLIX SOLACI Regional Sessions held at the Intercontinental Hotel in San Salvador, El Salvador between November 7 and 8,...

The El Salvador 2024 Sessions are coming soon

solaci - 0
The XLIX SOLACI 2024 Regional Sessions (17th Central America & the Caribbean) are approaching, and will take place in the city of San Salvador (El Salvador)....

Check out the best images of the Arequipa 2024 Sessions

solaci - 0
Review the highlights of the XVIII SOLACI Regional Sessions held at the Hanan Hotel in Arequipa, Peru between October 3 and 4, 2024. <!-- wp:tw/bwg...

Accesos

Adolfo Alsina 2653 · Piso 2H · CABA · Buenos Aires · Argentina · (5411) 4954 7173 · info@solaci.org · solaci.org · Términos de uso -Políticas de privacidad